Levofloxacin Noridem

Levofloxacin, the active ingredient in Levofloxacin Noridem, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a broad spectrum of serious bacterial infections in adult patients, including community‑acquired and hospital‑acquired pneumonia, complicated urinary tract, skin and intra‑abdominal infections.

GNH USA supplies Levofloxacin Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support global distribution, including temperature‑controlled logistics where required.

Levofloxacin is a fluoroquinolone antibacterial indicated for several serious infections.

- Community‑acquired pneumonia: effective treatment of bacterial pneumonia in adults. - Hospital‑acquired pneumonia: used to manage nosocomial lower respiratory infections. - Complicated urinary tract infections: treats infections of the urinary system resistant to first‑line agents. - Complicated skin and soft‑tissue infections: addresses severe bacterial skin infections. - Intra‑abdominal infections: employed for polymicrobial intra‑abdominal infections requiring IV therapy.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient hepatic enzyme rise.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: anaphylaxis, angioedema. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Hepatic failure: rare but potentially fatal liver injury.

Levofloxacin should be used with caution in specific clinical situations.

- Renal impairment: adjust dose based on renal function. - History of tendon disorders: avoid use or monitor closely for tendon pain. - QT prolongation risk: avoid in patients with known cardiac arrhythmias. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Concurrent NSAIDs: monitor for increased central nervous system toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids, sucralfate, iron or zinc supplements: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Theophylline: increased serum theophylline concentrations. - Cyclosporine: elevated cyclosporine levels. - Other QT‑prolonging agents: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: heightened CNS adverse effects. - Glucocorticoids: increased risk of tendon rupture. - Diabetes medications: possible alteration of glucose control. - Oral hypoglycemics: monitor blood sugar levels. - Certain antivirals (e.g., ritonavir): may affect levofloxacin plasma levels.